The Scientist

» Politics, disease/medicine and microbiology

Most Recent

image: Psychedelic Neuroimaging

Psychedelic Neuroimaging

By | April 13, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

0 Comments

image: Cancer Tissue Repository Launched

Cancer Tissue Repository Launched

By | April 11, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

0 Comments

image: Branching Out

Branching Out

By | April 11, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

0 Comments

image: Retracted Study’s Strategy Resurrected

Retracted Study’s Strategy Resurrected

By | April 11, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

0 Comments

image: Zooming In on an Antidepressant Target

Zooming In on an Antidepressant Target

By | April 6, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

0 Comments

image: Contributors

Contributors

By | April 1, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

0 Comments

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

0 Comments

image: Shooting for the Moon

Shooting for the Moon

By | April 1, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

4 Comments

image: Immune Influence

Immune Influence

By | April 1, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

0 Comments

image: Microbes Meet Cancer

Microbes Meet Cancer

By | April 1, 2016

“Ego dissolution,” and other things that happen to the human brain on LSD

4 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech